The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.95
Bid: 48.20
Ask: 49.15
Change: 0.00 (0.00%)
Spread: 0.95 (1.971%)
Open: 47.95
High: 47.95
Low: 47.95
Prev. Close: 47.95
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-closed-period update

13 Jan 2022 07:00

RNS Number : 2824Y
IP Group PLC
13 January 2022
 

FOR RELEASE ON

13 January 2022

 

IP Group plc - pre-closed-period update

 

Highlights

· FY21 profit anticipated to be above £425m (FY20: profit £185.4m)

· FY21 Hard NAV per share* anticipated to be above 165p (FY20: 125.3p), a return of at least 31%

· Net cash and deposits of £276m at 31 Dec 2021 (FY20: £203m)

· Portfolio companies well-funded having raised over £2bn in 2021 (FY20: £1.1bn)

 

IP Group plc (LSE: IPO) ("IP Group", "the Company" or "the Group"), the developer of intellectual property-based businesses, issues an unaudited pre-close update ahead of its results for the 12 months to 31 December 2021.

 

In financial terms, 2021 was another highly successful year with a large number of significant transactions including the flotation of Oxford Nanopore Technologies plc on the London Stock Exchange and the sales of Inivata Ltd and WaveOptics Ltd.

 

Consequently, the Directors currently expect the Group's profit for 2021 to be above £425m (FY20: profit £185.4m). Hard NAV per share is anticipated to be above 165 pence, a return of at least 31%.

 

The Group is in a strong financial position with net cash and deposits of £276m at year-end. The Group's portfolio is well funded with portfolio companies having raised over £2bn in 2021 (FY20: £1.1bn). This, combined with the exciting prospects and investment opportunities within the portfolio, gives us confidence for 2022.

 

IP Group expects to announce its 2021 results in mid-March.

 

Notes

 

*'Hard NAV per share' reflects net assets/total equity less goodwill and intangibles divided by outstanding shares.

 

The share price of Oxford Nanopore Technologies plc was 697 pence at 31 December 2021.

 

This update is based on unaudited information and is subject to change following the completion of the Group's usual full year-end reporting process and annual audit.

 

This announcement may contain forward looking statements. These statements reflect the Board's current view, are subject to a number of material risks and uncertainties and could change in the future. Factors which could cause or contribute to such changes include, but are not limited to, the general economic climate and market conditions, as well as specific factors relating to the financial or commercial prospects or performance of individual companies within the Group's portfolio.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBGDBCSBDGDD
Date   Source Headline
6th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSAppoints Prof. Clark Chair of ESG Ethics Committee
3rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jul 202012:02 pmRNSPrice Monitoring Extension
24th Jun 20202:39 pmRNSHolding(s) in Company
24th Jun 20208:10 amRNSHolding(s) in Company
23rd Jun 202011:37 amRNSLTIP & DBSP awards; Director/PDMR shareholding
18th Jun 20202:05 pmRNSResult of AGM
18th Jun 20207:00 amRNSAGM Statement
9th Jun 20205:47 pmRNSAGM update
5th Jun 20206:28 pmRNSHolding(s) in Company
26th May 202010:05 amRNSInivata receives $25m investment from NeoGenomics
26th May 20207:00 amRNSOxford Nanopore announces £48.4m of new funding
22nd May 20207:00 amRNSOxford Nanopore in development of covid19 test
21st May 20207:00 amRNSIP Group sells 12.25m shares in Ceres Power
21st May 20207:00 amRNSResult of secondary placing in Ceres Power
20th May 20204:48 pmRNSProposed secondary placing in Ceres Power Holdings
19th May 202012:02 pmRNSPrice Monitoring Extension
15th May 20204:36 pmRNSPrice Monitoring Extension
13th May 202012:08 pmRNSSecond Price Monitoring Extn
13th May 202012:03 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSFeaturespace completes £30m funding round
12th May 202012:02 pmRNSPrice Monitoring Extension
7th May 202012:02 pmRNSPrice Monitoring Extension
29th Apr 20204:57 pmRNSHolding(s) in Company
24th Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20203:45 pmRNSNotice of AGM
8th Apr 20205:04 pmRNSHolding(s) in Company
6th Apr 20205:45 pmRNSHolding(s) in Company
30th Mar 20202:12 pmRNSIssue of Equity
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20209:00 amRNSHolding(s) in Company
11th Mar 20207:01 amRNSDirectorate Change
11th Mar 20207:00 amRNSFinal Results
23rd Jan 20202:46 pmRNSHolding(s) in Company
22nd Jan 20205:12 pmRNSHolding(s) in Company
22nd Jan 202012:46 pmRNSBosch to increase holding in Ceres Power to c18%
17th Jan 20204:07 pmRNSHolding(s) in Company
3rd Jan 20202:18 pmRNSForm 8.3 - Hvivo plc
2nd Jan 20207:00 amRNSOxford Nanopore completes £109.5m financing
19th Dec 20197:00 amRNSDirector Declaration
17th Dec 20194:50 pmRNSShare Capital Reduction Effective
12th Dec 201910:52 amRNSHolding(s) in Company
10th Dec 20191:12 pmRNSOxford Nanopore selected as sequencing partner
4th Dec 20194:10 pmRNSHolding(s) in Company
28th Nov 20194:10 pmRNSHolding(s) in Company
26th Nov 201911:24 amRNSHolding(s) in Company
25th Nov 20191:59 pmRNSResult of General Meeting
22nd Nov 20195:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.